Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00855725 · ClinicalTrials.gov registry record
Affective Processing in Depression and Epilepsy
A clinical trial, sponsored by Northwell Health.
- Terminated
- Registry status
- 14
- Enrollment target
NCT00855725: Clinical Trial study, sponsored by Northwell Health.
NCT00855725 is a clinical trial that was terminated before completion, run by Northwell Health. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00855725 was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The goal of this study is to determine whether there are unique markers on neuroimaging that are associated with depression in epilepsy.
Interventions
- OTHER fMRI
- OTHER Hamilton Depression Rating Scale
- OTHER Beck's Depressive Inventory
- OTHER Interictal Dysphoric Disorder Inventory (IDDI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2008-06 |
| Est. Completion | 2009-06 |
Why NCT00855725 stopped before completion
NCT00855725 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which fMRI is the first listed.
NCT00855725 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00855725 about?
NCT00855725 is a clinical study titled "Affective Processing in Depression and Epilepsy". The goal of this study is to determine whether there are unique markers on neuroimaging that are associated with depression in epilepsy.
What is the current status of trial NCT00855725?
This trial is currently terminated. The enrollment target is 14 participants. The study started on 2008-06. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00855725?
The interventions under investigation include: fMRI (OTHER), Hamilton Depression Rating Scale (OTHER), Beck's Depressive Inventory (OTHER), Interictal Dysphoric Disorder Inventory (IDDI) (OTHER).
Who is sponsoring clinical trial NCT00855725?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia